Tropicamide effects on pupil size and pupillary light reflexes in Alzheimer's and Parkinson's disease

International Journal of Psychophysiology

Volumn 47, Issue 2, 2003, Pages 95-115

  Granholm, Eric ^a,b   Morris, Shaunna ^a,c   Galasko, Douglas ^a,c   Shults, Clifford ^a,c   Rogers, Erin ^a   Vukov, Boris ^a  

^a VA SAN DIEGO HEALTHCARE SYSTEM   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Alzheimer's disease; Light reflex; Parkinson's disease; Pupillary response; Tropicamide

Indexed keywords

SODIUM CHLORIDE; TROPICAMIDE;

AGED; ALZHEIMER DISEASE; ARTICLE; CHOLINERGIC SYSTEM; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DARKNESS; DIAGNOSTIC PROCEDURE; DISEASE COURSE; DOUBLE BLIND PROCEDURE; DRUG EFFECT; EYE MOVEMENT CONTROL; FEMALE; HUMAN; LATENT PERIOD; LIGHT; MALE; PARKINSON DISEASE; PUPIL; PUPIL REFLEX; PUPILLOGRAPHY;

AGED; ALZHEIMER DISEASE; FEMALE; HUMANS; LIGHT; MALE; MUSCARINIC ANTAGONISTS; OPHTHALMIC SOLUTIONS; PARKINSON DISEASE; PHOTIC STIMULATION; PUPIL; REFLEX, PUPILLARY; TROPICAMIDE;

EID: 0037306829     PISSN: 01678760     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0167-8760(02)00122-8     Document Type: Article

References (67)

1. Alexandridis E. Recent advances in the evaluation of afferent pupillary defects. J. Psychophysiol. 5:1991;241-247.
2. Diagnostic and Statistical Manual of Mental Disorders. fourth ed: 1994;American Psychiatric Association, Washington, DC.
3. Arai H., Terajima M., Nakagawa T., et al. Pupil dilatation assay by tropicamide is modulated by apolipoprotein E ε4 allele dosage in Alzheimer's disease. Clin. Neurosci. Neuropathol. 7:(4):1996;918-920.
4. Arendt T., Bigl V., Arendt A., Tennstedt A. Loss of neurons in the nucleus basalis of Meynert in Alzheimer's disease. Acta Neuropathol. 61:1983;101-108.
5. Beaumont S.M., Harris J.P., Leendertz J.A., Phillipson O.T. The pupillary light reflex in mild Parkinson's disease. Clin. Vision. Sci. 2:1987;123-129.
6. Caputo L., Casartelli M., Perrone C., et al. The eye test in recognition of late-onset Alzheimer's disease. Arch. Gerontol. Geriatrics. 27:1998;171-177.
7. Davies P., Maloney A.J. Selective loss of central cholinergic neurons in Alzheimer's Disease. Lancet. 2:1976;1403-1405.
8. Drummond P.D. The effect of light intensity and dose of dilute pilocarpine eyedrops on pupillary constriction in healthy subjects. Am. J. Ophthalmol. 112:1991;195-199.
9. Ferrario E., Molaschi M., Villa L., et al. Is video-pupillography useful in the diagnosis of Alzheimer's disease? Neurology. 50:(3):1998;642-644.
10. Fitz-Simon J.S., Waring S.C., Kokmen E., et al. Response of the pupil to tropicamide is not a reliable test for Alzheimer disease. Arch. Neurol. 54:(2):1997;155-159.
11. Fotiou F., Fountoulaks K.N., Tsolaki M., et al. Changes in pupil reaction to light in Alzheimer's disease patients: a preliminary report. Int. J. Psychophysiol. 37:2000;111-120.
12. Fridh M., Havelius U., Elofsson G., Hindfelt B. The pupillary response to tropicamide in Alzheimer's disease. Acta Ophthalmol. Scand. 74:(3):1996;276-279.
13. Gomez-Tortosa E., del Barrio A., Jimenez-Alfaro I. Pupil response to tropicamide in Alzheimer's disease and other neurodegenerative disorders. Acta Neurol. Scand. 94:(2):1996;104-109.
14. Gracon S.I. Tacrine in Alzheimer's disease. N. Engl. J. Med. 328:(11):1993;808-809.
15. Graff-Radford N.R., Lin S.C., Brazis P.W., Bolling J.P., et al. Tropicamide eyedrops cannot be used for reliable diagnosis of Alzheimer's disease. Mayo Clin. Proc. 72:(6):1997;495-504.
16. Growdon J.H., Graefe K., Tennis M., Hayden D., et al. Pupil dilation to tropicamide is not specific for Alzheimer disease. Arch. Neurol. 54:(7):1997;841-844.
17. Grunberger J., Linzmayer L., Walter H., et al. Psychophysiological diagnostics in alcohol dependency: Fourier analysis of pupillary oscillations and the receptor test for determination of cholinergic deficiency. Alcohol Alcohol. 33:(5):1998;541-548.
18. Grunberger J., Linzmayer L., Walter H., Rainer M., et al. Receptor test (pupillary dilatation after application of 0.01% tropicamide solution) and determination of central nervous activation (Fourier analysis of pupillary oscillations) in patients with Alzheimer's disease. Neuropsychobiology. 40:(1):1999;40-46.
19. Harris J.P. The pupil in Parkinson's disease. J. Psychophysiol. 5:1991;251-254.
20. Heijer J.C.D., Bollen W.L.E., Reulen J.P.H., et al. Autonomic nervous function in Huntington's disease. Arch. Neurol. 45:1988;309-312.
21. Heller P.H., Perry F., Jewett D.L., Levine J.D. Autonomic components of the human pupillary light reflex. Invest. Ophthal. Visual Sci. 31:1990;156-162.
22. Higuchi S., Matsushita S., Hasegawa Y., Muramatsu T., Arai H. Pupillary response to tropicamide in Japanese patients with alcoholic dementia, Alzheimer's disease, and vascular dementia. Exp. Neurol. 144:(1):1997;199-201.
23. Hunter S. The rostral mesencephalon in Parkinson's disease. Neuropathologica. 68:(1):1985;53-58.
24. Imamura Y., Mashima Y., Oshitari K., et al. Detection of dilated subarachnoid space around the optic nerve in patients with papilledema using T2 weighted fast spin echo imaging. J. Neurol. Neurosurg. Psychiatry. 60:(1):1996;108-109.
25. Jacobson D.M., Olson K.A. Influence of pupil size, anisocoria, and ambient light on pilocarpine miosis. Implications for supersensitivity testing. Ophthalmology. 100:(2):1993;275-280.
26. Kalman J., Kanka A., Magloczky E., Szoke A., et al. Increase mydriatic response to troplicamide is a sign of cholinergic hypersensitivity but not specific to late-onset sporadic type of Alzheimer's dementia. Biol. Psychiatry. 4:(18):1997;909-911.
27. Kaneyuki H., Mitsuno S., Nishida T., Yamada M. Enhanced miotic response to topical dilute pilocarpine in patients with Alzheimer's disease. Neurology. 50:1998;802-804.
28. Kardon R.H. Drop the Alzheimer's drop test. Neurology. 50:(3):1998;588-591.
29. Katz B. Detecting Alzheimer's disease, Letter to the Editor. Science. 267:1995;1578-1579.
30. Katz B., Van Patten P., Rothrock J.F., Katzman R. Optic nerve head drusen and pseudotumor cerebri. Arch. Neurol. 45:(1):1988;45-47.
31. Kono K., Miyao M., Ishihara S., et al. Hypersensitivity in the pupil dilation response to a cholinergic antagonist in patients with Alzheimer's disease and Down's syndrome). Nippon Ronen Igakkai Zasshi. 33:(11):1996;829-834.
32. Kurz A., Marquard R., Fremke S., Leipert K.P. Pupil dilation response to tropicamide: a biological test for Alzheimer's disease? Pharmacopsychiatry. 30:(1):1997;12-15.
33. Litvan I., FitzGibbon E.J. Can tropicamide eye drop response differentiate patients with progressive supranuclear palsy and Alzheimer's disease from healthy control subjects? Neurology. 47:(5):1996;1324-1326.
34. Loupe D.N., Newman N.J., Green R.C., et al. Pupillary response to tropicamide in patients with Alzheimer disease. Ophthalmology. 103:(3):1996;495-503.
35. Loewenfeld I.E. The Pupil: Anatomy, Physiology, and Clinical Applications. 14:1999;Butterworth-Heinemann, Boston.
36. Lowenstein O., Loewenfeld I.E. The pupil. Davson H. The Eye. 3:1969;Academic Press, New York.
37. Marquard R., Fremke S., Leipert K.P., Car H.P., Kurz A. Pupil dilation response to Tropicamide: a diagnostic marker for Alzheimer's Disease? Paper presented at the International Symposium on Alzheimer Research [Abstr.]. Alzheimer's Res. 1:1995;8.
38. Marx J.L., Kumar S.R., Thach A.B., Kiat-Winarko T., Frambach D.A. Detecting Alzheimer's disease, Letter to the Editor. Science. 267:1995;1577.
39. Mattis S. Mental status examination for organic mental syndrome in the elderly patient. Bellack L., Karasu T.B. Geriatric Psychiatry: A Handbook for Psychiatrists and Primary Care Physicians. 1976;77-120 Grune & Stratton, New York.
40. McKhann G., Drachman D., Folstein M., Katzman R., Price D., Stadlan E.M. Clinical diagnosis of Alzheimer's disease: Report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease. Neurology. 34:1984;939-944.
41. Meyer S., Gibb T., Jurkovich G.J. Evaluation and Significance of the pupillary light reflex in trauma patients. Ann. Emerg. Med. 22:(6):1993;125-130.
42. Micieli G., Tassorelli C., Martignoni E., Pacchetti C., et al. Disordered pupil reactivity in Parkinson's disease. Clin. Auton. Res. 1:(1):1991;55-58.
43. Naranjo C.A., Fourie J., Herrmann N., et al. Probing peripheral and central cholinergic system responses. J. Psychiatry Neurosci. 25:(4):2000;325-336.
44. Newman N.J. The eyes don't have it in Alzheimer's disease. Mayo Clin. Proc. 72:(6):1997;581-582.
45. Orskov L., Jakobsen J., Dupot E., et al. Autonomic function in parkinsonian patients relates to duration of disease. Neurology. 37:(7):1987;1173-1178.
46. Patterson T., Venables P.H. Bilateral skin conductance and the pupillary light-dark reflex: manipulation by chlorpromazine, haloperidol, scopolamine, and placebo. Psychopharmacology. 73:1981;63-69.
47. Perry E.K., Perry R.H., Blessed G., Tomlinson B.E. Necropsy evidence of central cholinergic deficits in senile dementia. Lancet. 1:1977;189.
48. Pomara N., Sitaram N. Detecting Alzheimer's disease, Letter to the Editor. Science. 267:(5204):1995;1579-1590. (discussion pp. 1580-1571).
49. Prettyman R., Bitsios P., Szabadi E. Altered pupillary size and darkness and light reflexes in Alzheimer's disease. J. Neurol. Neurosurg. Psychiatry. 62:(6):1997;665-668.
50. Procter A.W., Lowe S.L., Palmer A.M., et al. Topographical distribution of neurochemical changes in Alzheimer's disease. J. Neurol. Sci. 84:(2-3):1988;125-140.
51. Reitner A., Baumgartner I., Thuile C., et al. The mydriatic effect of tropicamide and its diagnostic use in Alzheimer's disease. Vision Res. 37:(1):1997;165-168.
52. Robles A., Tourino R., Gude F., Noya M. The tropicamide test in patients with dementia of Alzheimer type and fontotemporal dementia. Funct. Neurol.: New Trends in Adaptive Behavioral Disorders. 14:1999;203-207.
53. Scinto L.F.M., Daffner K.R., Dressler D., Rasnil B.I., et al. A potential noninvasive neurobiological test for Alzheimer's Disease. Science. 266:1994;1051-1054.
54. Scinto L.F., Wu C.K., Firla K.M., et al. Focal pathology in the Edinger-Westphal nucleus explains pupillary hypersensitivity in Alzheimer's disease. Acta Neuropathol. (Berl.). 97:(6):1999;557-564.
55. Sitaram N., Pomara N. Increased pupillary miotic response to pilocarpine in cognitively impaired elderly subjects. IRCS Med. Sci. 9:1981;409.
56. Spiers A.S., Calne D.B., Fayers P.M. Miosis during L-dopa therapy. Br. Med. J. 2:(7):1970;639-640.
57. Steinhauer S.R., Hakerem G. The pupillary response in cognitive psychophysiology and schizophrenia. Ann. N.Y. Acad. Sci. 658:1992;182-204.
58. Sullivan E.V., Lawrence R., Britten A.J. Experience in optimizing the tropicamide eye drop test as a diagnostic test of Alzheimer's disease. Paper presented at the 23rd Pupil Colloquium, Nottingham, United Kingdom. 1999.
59. Takagi A., Ishihara S., Kondo T., et al. Age effects on pupil dilation among Alzheimer's patients. J. Am. Geriatr. Soc. 47:(10):1999;1275-1276.
60. Tales A., Butler S.R., Troscianko T., Wilcock G. The pupillary light reflex in Alzheimer's disease. Paper presented at the 23rd Pupil Colloquium, Nottingham, United Kingdom. 1999.
61. Thal L.J. Clinical trials in Alzheimer disease. Terry R.D., Katzman R., Bick K.L. Alzheimer Disease. 1994;431-444 Raven Press, New York.
62. Treloar A., Assin M., Macdonald A. Detecting Alzheimer's disease, Letter to the Editor. Science. 267:1995;1578.
63. Treloar A., Assin M., Macdonald A.J. Pupillary response to topical tropicamide as a marker for Alzheimer's disease. Br. J. Clin. Pharmacol. 41:(3):1996;256-257.
64. Van Diemen H.A., Van Dongen M.M., Nauta J.J., et al. Pupillary light reflex latency in patients with multiple sclerosis. Electroenceph. Clin. Neurophysiol. 82:(3):1992;213-219.
65. Weintraub M.I., Gaasterland D., Van Woert M.H. Pupillary effects of levodopa therapy. Development of anisocoria in latent Horner's syndrome. N. Engl. J. Med. 283:(3):1970;120-123.
66. Whitehouse P.J., Price D.J., Struble R.G., Clark A.W., Coyle J.T., DeLong M.R. Alzheimer's disease and senile dementia: loss of neurons in the basal forebrain. Science. 215:1982;1237-1239.
67. Woodruff P.W., Benson R.R., Bandettini P.A., et al. Modulation of auditory and visual cortex by selective attention is modality-dependent. NeuroReport. 7:(12):1996;1909-1913.